Novo Nordisk A/S class B (NOVO_B): Arc Cycle analysis
Overview:Based on Arc Cycle Analysis applied to the 30m chart, Novo Nordisk is interacting with the 1 (100%) Support Arc within the current Arc Cycle. Price is holding above this Support Arc, suggesting the potential for a bullish rebound toward the next Resistance Arc.
|
Metric |
Reading |
|
Market bias |
Neutral-Bullish |
|
Preferred scenario |
Potential Rebound |
|
Primary target zone |
306.00 |
|
Scenario invalidation |
Sustained close below 294.00 |
|
Current arc level |
Support Arc (1 / 100%) |
|
Cycle status |
Testing Support Arc |
|
Arc integrity |
Strong |
Market outlook
Price is holding above the 1 (100%) Support Arc, indicating that this Arc continues to provide support within the current Arc Cycle. If the Support Arc continues to hold, a rebound toward 306.00 price becomes the preferred scenario.
Conversely, a sustained 30m close below the Support Arc at 294.00 would invalidate the bullish scenario and shift the outlook toward the next lower Support Arc.
About The Author
